Cardiac glycosides decrease prostate specific antigen expression by down-regulation of prostate derived Ets factor

Journal of Urology

Volumn 184, Issue 5, 2010, Pages 2158-2164

  Juang, Horng Heng ^a,b   Lin, Yu Fen ^a   Chang, Phei Lang ^b   Tsui, Ke Hung ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Gene expression; Prostate; Prostate specific antigen; Prostatic neoplasms; SPDEF protein, human

Indexed keywords

DIGITOXIN; DIGOXIN; OUABAIN; PROSTATE SPECIFIC ANTIGEN; CARDIAC GLYCOSIDE; CARDIOTONIC AGENT; SPDEF PROTEIN, HUMAN; TRANSCRIPTION FACTOR ETS;

ARTICLE; ATTENUATION; CELL PROLIFERATION; CELL STRAIN LNCAP; DOWN REGULATION; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSIENT EXPRESSION; TREATMENT OUTCOME; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL CULTURE;

CARDIAC GLYCOSIDES; CARDIOTONIC AGENTS; DIGITOXIN; DIGOXIN; DOWN-REGULATION; GENE EXPRESSION REGULATION; HUMANS; MALE; OUABAIN; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-ETS; TUMOR CELLS, CULTURED;

EID: 77957844932     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.06.093     Document Type: Article

References (26)

1. T.A. Stamey, M. Caldwell, and J.E. McNeal The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J Urol 172 2004 1297
2. W.J. Catalona, P.C. Southwick, and K.M. Slawin Comparison of percent free PSA, PSA density and age-specific PSA cutoffs for prostate cancer detection and staging Urology 56 2000 255
3. W. Schoner, and G. Scheiner-Bobis Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth Am J Physiol Cell Physiol 293 2007 C509
4. J.Y. Yen, W.J. Huang, and S.F. Kan Inhibitory effects of digitalis on the proliferation of androgen dependent and independent prostate cancer cells J Urol 166 2001 1937
5. Y.T. Huang, S.C. Chueh, and C.M. Teng Investigation of ouabain-induced anticancer effect in human androgen-independent prostate cancer PC-3 cells Biochem Pharmacol 67 2004 723
6. 3H]noradrenaline release in human prostate J Urol 163 2000 338
7. P. Oettgen, E. Finger, and Z. Sun PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression J Biol Chem 275 2000 1216
8. A.K. Sood, R. Saxena, and J. Groth Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression Hum Pathol 38 2007 1628
9. P.H. Johnson, R.P. Walker, and S.W. Jones Multiplex gene expression analysis for high-throughput drug discovery: screening and analysis of compounds affecting genes overexpressed in cancer cells Mol Cancer Ther 1 2002 1293
10. P. Thelen, T. Peter, and A. Hunermund Phytoestrogens from Belamcanda chinensis regulate the expression of steroid receptors and related cofactors in LNCaP prostate cancer cells BJU Int 100 2007 199
11. W. Schoner Endogenous cardiac glycosides, a new class of steroid hormones Eur J Biochem 269 2002 2440
12. K.H. Tsui, T.H. Feng, and C.M. Lin Curcumin blocks the activating of androgen and interlukin-6 on prostate specific antigen expression in human prostatic carcinoma cells J Androl 29 2008 661
13. K.H. Tsiu, P.L. Chang, and H.T. Lin Down-regulation of the prostate specific antigen promoter by p53 in human prostate cancer cells J Urol 172 2004 2305
14. H.H. Juang Nitroprusside stimulates mitochondrial aconitase gene expression through the cyclic adenosine 3′,5′-monosphosphate signal transduction pathway in human prostate carcinoma cells Prostate 61 2004 92
15. K.H. Tsiu, L. Wu, and P.L. Chang Identifying the combination of the transcriptional regulatory sequences on prostate specific antigen and human glandular kallikrein genes J Urol 172 2004 2029
16. A. Seth, and D.K. Waston ETS transcription factors and their emerging roles in human cancer Eur J Cancer 41 2005 2462
17. S.A. Tomlins, A. Bjartell, and A.M. Chinnaiyan ETS gene fusions in prostate cancer: from discovery to daily clinical practice Eur Urol 56 2009 275
18. C. Cai, H. Wang, and Y. Xu Reactivation of androgen receptor-regulated TMPRSS2: EGR gene expression in castration-resistant prostate cancer Cancer Res 69 2009 6027
19. S.A. Tomlins, B. Laxman, and S. Varambally Role of the TMPRSS2: EGR gene fusion in prostate cancer Neoplasia 10 2008 177
20. X. Gu, L.F. Zerbini, and H.H. Otu Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells Cancer Res 67 2007 4219
21. A. Magklara, T.J. Brown, and E.P. Diamandis Characterization of androgen receptor and nuclear receptor co-regulator expression in human breast cancer cell lines exhibiting differential regulation of kallikreins 2 and 3 Int J Cancer 100 2002 507
22. T. Hsu, M. Trojanowska, and D.K. Watson Ets proteins in biological control and cancer J Cell Biochem 91 2004 896
23. +-ATPase in human breast cancer cells Mol Pharmacol 67 2005 929
24. M. Lopez-Lazaro Digitoxin as an anticancer agent with selectivity for cancer cells: possible mechanisms involved Expert Opin Ther Targets 11 2007 1043
25. Q. Yang, W. Huang, and C. Jozwik Cardiac glycosides inhibit TNF-α/NF-κB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor PNAS 102 2005 9631
26. B.G. Katzung, and W.W. Parmley Cardiac glycosides and other drugs used in congestive heart failure B.G. Katzung, Basic and Clinical Pharmacology 8th ed. 2000 Appleton & Lange New York 200 218